3 Reasons Why It’s a Good Time to Buy PFE Stock
To say the Covid-19 vaccination wave in 2021 moved the needle for Pfizer (NYSE:PFE) stock is an understatement. Revenue nearly doubled thanks to its vaccine candidate (Comirnaty), which the pharma firm co-developed with BioNTech (NASDAQ:BNTX). PFE stock performed strongly as well during this timeframe. So far in 2022, however, Pfizer’s performance has been far less […]
3 Reasons Why It’s a Good Time to Buy PFE Stock Read More »